Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Blood glucose and stroke.

Helgason CM.

Curr Treat Options Cardiovasc Med. 2012 Jun;14(3):284-7. doi: 10.1007/s11936-012-0178-5.

PMID:
22565397
[PubMed]
2.

Principled versus statistical thinking in diagnosis and treatment of stroke.

Helgason CM, Jobe TH.

Curr Treat Options Cardiovasc Med. 2010 Jun;12(3):292-6. doi: 10.1007/s11936-010-0073-x. Epub 2010 Apr 14.

PMID:
20461119
[PubMed]
Free PMC Article
3.

Artificial adaptive systems and fuzzy measures for translation of clinical trial results to the bedside.

Helgason CM.

Curr Treat Options Cardiovasc Med. 2009 Jun;11(3):187-90.

PMID:
19433013
[PubMed]
4.

Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.

Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH.

Cerebrovasc Dis. 2009;27(6):585-93. doi: 10.1159/000214223. Epub 2009 Apr 24.

PMID:
19390185
[PubMed - indexed for MEDLINE]
5.

Measurable prediction for the single patient and the results of large double blind controlled randomized trials.

Helgason CM, Jobe TH.

PLoS One. 2008 Apr 2;3(4):e1909. doi: 10.1371/journal.pone.0001909.

PMID:
18382682
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Platelet aggregation and recruitment with aspirin-clopidogrel therapy.

Helgason CM, Grossi E, Pandey D, Valika A, Cursio J, Brace LD.

Cerebrovasc Dis. 2008;25(5):392-400. doi: 10.1159/000121339. Epub 2008 Mar 17.

PMID:
18349532
[PubMed - indexed for MEDLINE]
7.

Factors influencing warfarin dose requirements in African-Americans.

Momary KM, Shapiro NL, Viana MA, Nutescu EA, Helgason CM, Cavallari LH.

Pharmacogenomics. 2007 Nov;8(11):1535-44.

PMID:
18034618
[PubMed - indexed for MEDLINE]
8.

Warfarin in patients with stroke and reasons for discontinuation.

Helgason CM, Do MA, Nutescu E.

J Stroke Cerebrovasc Dis. 2004 Mar-Apr;13(2):70-3.

PMID:
17903952
[PubMed]
9.

Editorial commentary.

Fisher M, Stirling Meyer J, Malik GM, Helgason CM.

J Stroke Cerebrovasc Dis. 1999 Nov-Dec;8(6):i-ii. No abstract available.

PMID:
17895188
[PubMed]
10.

The difference between a dynamic and mechanical approach to stroke treatment.

Helgason CM.

Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):213-20.

PMID:
17601385
[PubMed]
11.

Carotid endarterectomy for asymptomatic plaque.

Helgason CM.

Neurol Clin. 2006 Nov;24(4):661-7. Review.

PMID:
16935194
[PubMed - indexed for MEDLINE]
12.

Thrombophilia in ischemic stroke subtypes: implications for treatment.

Helgason CM.

Curr Treat Options Cardiovasc Med. 2006 May;8(3):259-66.

PMID:
16635446
[PubMed]
13.

Sex difference in the antiplatelet effect of aspirin in patients with stroke.

Cavallari LH, Helgason CM, Brace LD, Viana MA, Nutescu EA.

Ann Pharmacother. 2006 May;40(5):812-7. Epub 2006 Apr 11.

PMID:
16608908
[PubMed - indexed for MEDLINE]
14.

From fuzzy logic toward plurimonism: the science of active and empathic observation.

Sripada BN, Jobe TH, Helgason CM.

IEEE Trans Syst Man Cybern B Cybern. 2005 Dec;35(6):1328-39.

PMID:
16366258
[PubMed - indexed for MEDLINE]
15.
16.

Fuzzy logic and continuous cellular automata in warfarin dosing of stroke patients.

Helgason CM, Jobe TH.

Curr Treat Options Cardiovasc Med. 2005 Jul;7(3):211-8.

PMID:
16004852
[PubMed]
17.

Fuzzy logic and causal reasoning with an 'n' of 1 for diagnosis and treatment of the stroke patient.

Helgason CM, Jobe TH.

Expert Rev Neurother. 2004 Mar;4(2):249-54. Review.

PMID:
15853566
[PubMed - indexed for MEDLINE]
18.

New blood thinner offers first potential alternative in 50 years: ximelagatran.

Nutescu EA, Helgason CM, Briller J, Schwertz DW.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):374-83. Review.

PMID:
15529058
[PubMed - indexed for MEDLINE]
19.

The application of fuzzy logic to the prescription of antithrombotic agents in the elderly.

Helgason CM.

Drugs Aging. 2004;21(11):731-6. Review.

PMID:
15323578
[PubMed - indexed for MEDLINE]
20.

Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors.

Nutescu EA, Helgason CM.

Pharmacotherapy. 2004 Jul;24(7 Pt 2):82S-87S. Review.

PMID:
15317403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk